These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38773818)

  • 21. Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study.
    Lin E; Balogh R; McGarry C; Selick A; Dobranowski K; Wilton AS; Lunsky Y
    BMJ Open; 2016 Sep; 6(9):e011638. PubMed ID: 27591020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of intellectual and developmental disabilities among first generation adult newcomers, and the health and health service use of this group: A retrospective cohort study.
    Durbin A; Jung JKH; Chung H; Lin E; Balogh R; Lunsky Y
    PLoS One; 2019; 14(6):e0215804. PubMed ID: 31220086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid Enrollees.
    Keefe RJ; Cummings ADL; Smith AE; Greeley CS; Van Horne BS
    J Child Adolesc Psychopharmacol; 2023 May; 33(4):149-155. PubMed ID: 37204275
    [No Abstract]   [Full Text] [Related]  

  • 25. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Use of Psychotropic Medication in Iranian Children with Developmental Disabilities.
    McConkey R; Samadi SA; Mahmoodizadeh A; Taggart L
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33924699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotic initiation among adults with intellectual and developmental disabilities in Ontario: a population-based cohort study.
    Gomes T; Khuu W; Tadrous M; Vigod S; Cobigo V; Lunsky Y
    BMJ Open; 2019 Jul; 9(7):e028125. PubMed ID: 31366646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brief report: cervical cancer screening in women with intellectual and developmental disabilities who have had a pregnancy.
    Brown HK; Plourde N; Ouellette-Kuntz H; Vigod S; Cobigo V
    J Intellect Disabil Res; 2016 Jan; 60(1):22-7. PubMed ID: 26359630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication Management in Adults With Intellectual and Developmental Disabilities: Psychiatric Pharmacists in Primary Care.
    Moon E; Snyder SD; Williams A; Allen S; Simmons E
    Am J Intellect Dev Disabil; 2024 Nov; 129(6):446-452. PubMed ID: 39467560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How HIV affects health and service use for adults with intellectual and developmental disabilities.
    Durbin A; Brown HK; Bansal S; Antoniou T; Jung JKH; Lunsky Y
    J Intellect Disabil Res; 2017 Jul; 61(7):682-696. PubMed ID: 28612475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using administrative health data to identify individuals with intellectual and developmental disabilities: a comparison of algorithms.
    Lin E; Balogh R; Cobigo V; Ouellette-Kuntz H; Wilton AS; Lunsky Y
    J Intellect Disabil Res; 2013 May; 57(5):462-77. PubMed ID: 23116328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons learned from our elders: how to study polypharmacy in populations with intellectual and developmental disabilities.
    Stortz JN; Lake JK; Cobigo V; Ouellette-Kuntz HM; Lunsky Y
    Intellect Dev Disabil; 2014 Feb; 52(1):60-77. PubMed ID: 24635692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matching Special Olympics registration data with administrative health databases: Feasibility and health status differences in children and youth with IDD.
    Lloyd M; Dobranowski K; Cheng SY; Temple VA; Foley JT; Lunsky Y; Lin E; Balogh R
    Disabil Health J; 2022 Jul; 15(3):101319. PubMed ID: 35443929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High health care costs among adults with intellectual and developmental disabilities: a population-based study.
    Lunsky Y; De Oliveira C; Wilton A; Wodchis W
    J Intellect Disabil Res; 2019 Feb; 63(2):124-137. PubMed ID: 30381849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychiatric Presentations and Medication Use in Older Adults With Intellectual and Developmental Disabilities.
    Wise E; Holingue C; Klein A; Caoili A; Charlot L; Barnhill J; Beasley JB
    Am J Geriatr Psychiatry; 2022 Jan; 30(1):65-77. PubMed ID: 34210596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy in Women With Intellectual and Developmental Disabilities.
    Brown HK; Lunsky Y; Wilton AS; Cobigo V; Vigod SN
    J Obstet Gynaecol Can; 2016 Jan; 38(1):9-16. PubMed ID: 26872750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotropic and Anticonvulsant Medication: Individuals With Intellectual and Developmental Disabilities Who Transitioned to the Community From an Institution.
    Kelly S; Su Y
    Intellect Dev Disabil; 2015 Aug; 53(4):289-300. PubMed ID: 26214558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of COVID-19 on psychoactive medication use among individuals with intellectual and developmental disabilities in Ontario, Canada: A repeated cross-sectional study.
    Guan Q; Garg R; McCormack D; Lunsky Y; Tadrous M; Campbell T; Gomes T
    Disabil Health J; 2024 Oct; 17(4):101649. PubMed ID: 38876963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of psychotropic medications in adults with intellectual disability: A systematic review and meta-analysis.
    Song M; Rubin BS; Ha JW; Ware RS; Doan TN; Harley D
    Aust N Z J Psychiatry; 2023 May; 57(5):661-674. PubMed ID: 36700564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.